Haleon plc (ETR:H6D0)
Germany · Delayed Price · Currency is EUR 4.230
-0.089 (-2.06%)
At close: Jul 11, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Oral Health | 3.31B | Log In | Log In | Log In | Log In | Upgrade |
Oral Health Growth | 5.00% | Log In | Log In | Log In | Log In | Upgrade |
Vitamins, Minerals and Supplement | 1.70B | Log In | Log In | Log In | Log In | Upgrade |
Vitamins, Minerals and Supplement Growth | 1.99% | Log In | Log In | Log In | Log In | Upgrade |
Pain Relief | 2.56B | Log In | Log In | Log In | Log In | Upgrade |
Pain Relief Growth | -1.04% | Log In | Log In | Log In | Log In | Upgrade |
Respiratory Health | 1.68B | Log In | Log In | Log In | Log In | Upgrade |
Respiratory Health Growth | -1.42% | Log In | Log In | Log In | Log In | Upgrade |
Digestive Health and Other | 1.98B | Log In | Log In | Log In | Log In | Upgrade |
Digestive Health and Other Growth | -9.89% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
North America | 4.04B | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | -2.26% | Log In | Log In | Log In | Log In | Upgrade |
EMEA & LatAm | 4.63B | Log In | Log In | Log In | Log In | Upgrade |
EMEA & LatAm Growth | -0.22% | Log In | Log In | Log In | Log In | Upgrade |
APAC | 2.56B | Log In | Log In | Log In | Log In | Upgrade |
APAC Growth | 1.38% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
North America Adjusted Operating Profit | 1.00B | Log In | Log In | Log In | Log In | Upgrade |
North America Adjusted Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EMEA & LatAm Adjusted Operating Profit | 1.05B | Log In | Log In | Log In | Log In | Upgrade |
EMEA & LatAm Adjusted Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
APAC Adjusted Operating Profit | 539.00M | Log In | Log In | Log In | Log In | Upgrade |
APAC Adjusted Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Corporate Adjusted Operating Profit | -93.00M | Log In | Log In | Log In | Log In | Upgrade |
Corporate Adjusted Operating Profit Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Organic Revenue Growth | 5.00% | Log In | Log In | Log In | Log In | Upgrade |
Sales Growth due to Price | 3.70% | Log In | Log In | Log In | Log In | Upgrade |
Sales Growth due to Volume/Mix | 1.30% | Log In | Log In | Log In | Log In | Upgrade |